• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从肠道微生物群角度重新审视肉碱在心脏病中的作用。

Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota.

作者信息

Demarquoy Jean

机构信息

Unité Mixte de Recherche Procédés Alimentaires et Microbiologiques (UMR PAM), Institut Agro, Institut National de Recherche Pour L'agriculture, L'alimentation et L'environnement (INRAE), Université de Bourgogne, 21000 Dijon, France.

出版信息

Nutrients. 2024 Dec 9;16(23):4244. doi: 10.3390/nu16234244.

DOI:10.3390/nu16234244
PMID:39683637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11644639/
Abstract

L-Carnitine, sourced from red meat, dairy, and endogenous synthesis, plays a vital role in fatty acid metabolism and energy production. While beneficial for cardiovascular, muscular, and neural health, its interaction with the gut microbiota and conversion into trimethylamine (TMA) and trimethylamine N-oxide (TMAO) raise concerns about heart health. TMAO, produced through the gut-microbial metabolism of L-carnitine and subsequent liver oxidation, is associated with cardiovascular risks, including atherosclerosis, heart attacks, and stroke. It contributes to cholesterol deposition, vascular dysfunction, and platelet aggregation. Omnivorous diets, rich in L-carnitine, are associated with higher TMAO levels compared to plant-based diets, which are linked to lower cardiovascular disease risks. Dietary interventions, such as increasing fiber, polyphenols, and probiotics, can modulate the gut microbiota to reduce TMAO production. These strategies seek to balance L-carnitine's benefits with its potential risks related to TMAO production. Future research should focus on personalized approaches to optimize L-carnitine use while mitigating its cardiovascular impacts, exploring microbial modulation and dietary strategies to minimize the TMAO levels and associated risks.

摘要

左旋肉碱来源于红肉、乳制品以及内源性合成,在脂肪酸代谢和能量产生过程中发挥着至关重要的作用。虽然它对心血管、肌肉和神经健康有益,但其与肠道微生物群的相互作用以及转化为三甲胺(TMA)和氧化三甲胺(TMAO)引发了人们对心脏健康的担忧。TMAO是通过左旋肉碱的肠道微生物代谢以及随后的肝脏氧化产生的,与心血管风险相关,包括动脉粥样硬化、心脏病发作和中风。它会导致胆固醇沉积、血管功能障碍和血小板聚集。与植物性饮食相比,富含左旋肉碱的杂食性饮食与更高的TMAO水平相关,而植物性饮食与较低的心血管疾病风险相关。饮食干预措施,如增加纤维、多酚和益生菌的摄入,可以调节肠道微生物群以减少TMAO的产生。这些策略旨在平衡左旋肉碱的益处与其与TMAO产生相关的潜在风险。未来的研究应专注于个性化方法,以优化左旋肉碱的使用,同时减轻其对心血管的影响,探索微生物调节和饮食策略,以尽量降低TMAO水平及相关风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ce/11644639/88ca24f5b05f/nutrients-16-04244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ce/11644639/26105dd1c8e9/nutrients-16-04244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ce/11644639/88ca24f5b05f/nutrients-16-04244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ce/11644639/26105dd1c8e9/nutrients-16-04244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ce/11644639/88ca24f5b05f/nutrients-16-04244-g002.jpg

相似文献

1
Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota.从肠道微生物群角度重新审视肉碱在心脏病中的作用。
Nutrients. 2024 Dec 9;16(23):4244. doi: 10.3390/nu16234244.
2
l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.杂食饮食中的左旋肉碱在人体内诱导动脉粥样硬化的肠道微生物途径。
J Clin Invest. 2019 Jan 2;129(1):373-387. doi: 10.1172/JCI94601. Epub 2018 Dec 10.
3
The microbial gbu gene cluster links cardiovascular disease risk associated with red meat consumption to microbiota L-carnitine catabolism.微生物 gbu 基因簇将与食用红色肉类相关的心血管疾病风险与微生物组 L-肉碱代谢联系起来。
Nat Microbiol. 2022 Jan;7(1):73-86. doi: 10.1038/s41564-021-01010-x. Epub 2021 Dec 23.
4
Gut microbes with the genes determine TMAO production from L-carnitine intake and serve as a biomarker for precision nutrition.携带这些基因的肠道微生物决定了从左旋肉碱摄入中生成氧化三甲胺的过程,并作为精准营养的生物标志物。
Gut Microbes. 2025 Dec;17(1):2446374. doi: 10.1080/19490976.2024.2446374. Epub 2024 Dec 26.
5
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.肠道微生物对左旋肉碱(红肉中的一种营养物质)的代谢会促进动脉粥样硬化。
Nat Med. 2013 May;19(5):576-85. doi: 10.1038/nm.3145. Epub 2013 Apr 7.
6
Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development.调节肠道微生物群衍生代谢物氧化三甲胺的膳食生物活性成分。功能性食品开发的新机遇。
Food Funct. 2020 Aug 1;11(8):6745-6776. doi: 10.1039/d0fo01237h. Epub 2020 Jul 20.
7
Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.通过改变左旋肉碱的微生物降解来抑制肠道微生物群依赖的促动脉粥样硬化三甲胺 N-氧化物的产生。
Life Sci. 2014 Nov 11;117(2):84-92. doi: 10.1016/j.lfs.2014.09.028. Epub 2014 Oct 7.
8
γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.γ-丁甜菜碱是左旋肉碱在肠道微生物代谢为氧化三甲胺过程中的一种促动脉粥样硬化中间体。
Cell Metab. 2014 Nov 4;20(5):799-812. doi: 10.1016/j.cmet.2014.10.006.
9
Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.饮食因素、肠道微生物群和血清三甲胺 N-氧化物与西班牙裔社区健康研究/拉丁裔研究中的心血管疾病相关。
Am J Clin Nutr. 2021 Jun 1;113(6):1503-1514. doi: 10.1093/ajcn/nqab001.
10
Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice.通过肉碱挑战试验在人和无菌小鼠中鉴定 TMAO 产生表型和宿主-饮食-肠道失调。
Gut. 2019 Aug;68(8):1439-1449. doi: 10.1136/gutjnl-2018-317155. Epub 2018 Oct 30.

引用本文的文献

1
Metabolic Characteristics of Obese Adolescents with Different Degrees of Weight Loss After Identical Exercise Training Intervention.相同运动训练干预后不同减重程度肥胖青少年的代谢特征
Metabolites. 2025 May 7;15(5):313. doi: 10.3390/metabo15050313.

本文引用的文献

1
Role of L-carnitine in Cardiovascular Health: Literature Review.左旋肉碱在心血管健康中的作用:文献综述
Cureus. 2024 Sep 26;16(9):e70279. doi: 10.7759/cureus.70279. eCollection 2024 Sep.
2
Role of Trimethylamine N-Oxide in Heart Failure.氧化三甲胺在心力衰竭中的作用。
Rev Cardiovasc Med. 2024 Jul 2;25(7):240. doi: 10.31083/j.rcm2507240. eCollection 2024 Jul.
3
Effect of reducing saturated fat intake on cardiovascular disease in adults: an umbrella review.减少饱和脂肪摄入量对成年人心血管疾病的影响:伞式评价。
Front Public Health. 2024 Jun 3;12:1396576. doi: 10.3389/fpubh.2024.1396576. eCollection 2024.
4
Microbial metabolites as modulators of host physiology.微生物代谢物作为宿主生理学的调节剂。
Adv Microb Physiol. 2024;84:83-133. doi: 10.1016/bs.ampbs.2023.12.001. Epub 2024 Jan 16.
5
Alteration of the gut microbiome in patients with heart failure: A systematic review and meta-analysis.心力衰竭患者肠道微生物组的改变:系统评价和荟萃分析。
Microb Pathog. 2024 Jul;192:106647. doi: 10.1016/j.micpath.2024.106647. Epub 2024 May 23.
6
L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review.L-肉碱治疗精神和神经表现的系统评价
Nutrients. 2024 Apr 20;16(8):1232. doi: 10.3390/nu16081232.
7
The Effects of L-Carnitine Supplementation on Weight Loss, Glycemic Control, and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Systematic Review and Dose-response Meta-Analysis of Randomized Controlled Trials.左旋肉碱补充对 2 型糖尿病患者体重减轻、血糖控制和心血管危险因素的影响:系统评价和随机对照试验的剂量反应荟萃分析。
Clin Ther. 2024 May;46(5):404-410. doi: 10.1016/j.clinthera.2024.03.002. Epub 2024 Apr 9.
8
Research Progress in the Relationship Between Trimethylamine Oxide and Coronary Heart Disease.三甲基胺氧化物与冠心病关系的研究进展。
Altern Ther Health Med. 2024 Nov;30(11):220-227.
9
Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.肠道微生物组及其在心血管疾病中的治疗干预作用。
Front Immunol. 2024 Jan 26;15:1321395. doi: 10.3389/fimmu.2024.1321395. eCollection 2024.
10
Trimethylamine-N-oxide and cerebral stroke risk: A review.氧化三甲胺与脑卒中风险:综述
Neurobiol Dis. 2024 Mar;192:106423. doi: 10.1016/j.nbd.2024.106423. Epub 2024 Jan 28.